Sma News & Perspectives

Plans Advance for Biomarkers Panel to Assess Drug-induced Skeletal Muscle Injury

Informações:

Sinopsis

SMA News Today’s multimedia associate, Price Wooldridge, discusses plans being advanced for a biomarkers panel to assess drug-induced skeletal muscle injury in SMA. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/